BFA
ARKG icon

Brendel Financial Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

Brendel Financial Advisors’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-577
Closed -$53K – 74
2021
Q2 		$53K Buy
+577
New +$49.1K 0.03% 169
2021
Q1 		– Sell
-56,220
Closed -$5.24M – 90
2020
Q4 		$5.24M Buy
56,220
+478
+0.9% +$38.1K 3.57% 4
2020
Q3 		$3.55M Sell
55,742
-1,362
-2% -$79.8K 2.84% 7
2020
Q2 		$2.98M Buy
+57,104
New +$2.45M 2.57% 8

Other funds holding ARKG

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Brendel Financial Advisors's ARKG Position: Q3 2021 in Review

Brendel Financial Advisors sold out of ARK Genomic Revolution ETF (ARKG) in Q3 2021, closing a stake of 577 shares — an estimated $53K sold.

Brendel Financial Advisors first reported a position in ARKG in Q2 2020 and held it in 4 quarters. The position peaked at $5.24M in Q4 2020. 468 funds tracked by Wall St. Rank hold ARKG as of Q3 2021.

  • Brendel Financial Advisors reported no remaining ARK Genomic Revolution ETF position as of Q3 2021 after selling out during the quarter.
  • Brendel Financial Advisors sold 577 ARK Genomic Revolution ETF shares in Q3 2021, an estimated $53K.
  • Brendel Financial Advisors first reported a position in ARK Genomic Revolution ETF in Q2 2020 and held it in 4 quarters.
  • Brendel Financial Advisors's ARK Genomic Revolution ETF position peaked at $5.24M in Q4 2020.
  • 468 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2021.

Based on Brendel Financial Advisors's 13F filing for Q3 2021, filed 26 Oct 2021.